Clinical Drug Experience Knowledgebase

Acute Kidney Injury (Phase 1)

Acute Lung Injury (Phase 4)

Adenocarcinoma (Phase 3)

Alzheimer Disease (Phase 3)

Amyotrophic Lateral Sclerosis (Phase 2)

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Atrial Fibrillation (Phase 3)

Atypical Hemolytic Uremic Syndrome (Phase 2)

Azotemia (Phase 2)

Bone Neoplasms (Phase 1)

Breast Neoplasms (Phase 4)

Bronchial Spasm (Phase 4)

Bronchopulmonary Dysplasia (Phase 3)

Cancer Pain (Phase 4)

Carcinoma (Phase 4)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 4)

Carcinoma, Renal Cell (Phase 4)

Carcinoma, Squamous Cell (Phase 3)

Cardiac Output, Low (Phase 3)

Cardiovascular Diseases (Phase 3)

Colonic Neoplasms (Phase 3)

Colorectal Neoplasms (Phase 2)

Congenital Abnormalities (Phase 2)

Coronary Artery Disease (Phase 3)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Diabetic Nephropathies (Phase 3)

Diabetic Retinopathy (Phase 3)

Drug-Related Side Effects and Adverse Reactions (Phase 4)

Eclampsia (Phase 3)

Endometrial Neoplasms (Phase 3)

Epilepsies, Partial (Phase 4)

Epilepsy (Phase 4)

Esophageal Neoplasms (Phase 3)

Fallopian Tube Neoplasms (Phase 2)

Gastroenteritis (Phase 3)

Glioblastoma (Phase 2)

Glioma (Phase 2)

Glomerulonephritis (Phase 2)

Glomerulonephritis, Membranoproliferative (Phase 2)

Glomerulosclerosis, Focal Segmental (Phase 3)

Head and Neck Neoplasms (Phase 3)

Heart Diseases (Phase 3)

Heart Failure (Phase 3)

Hemangioma, Cavernous, Central Nervous System (Phase 2)

Hemolysis (Phase 2)

Hemolytic-Uremic Syndrome (Phase 2)

Hodgkin Disease (Phase 2)

Hyperparathyroidism (Phase 2)

Hyperparathyroidism, Secondary (Phase 2)

Hypersensitivity (Phase 3)

Hypertension (Phase 3)

Hypertrophy (Phase 3)

Hypertrophy, Left Ventricular (Phase 3)

Hyponatremia (Phase 2)

Infarction (Phase 3)

Infections (Phase 4)

Inflammation (Phase 2)

Ischemia (Phase 3)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 3)

Leiomyosarcoma (Phase 2)

Leukemia (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Liposarcoma (Phase 2)

Liver Neoplasms (Phase 2)

Lung Neoplasms (Phase 3)

Lymphoma (Phase 2)

Mesothelioma (Phase 2)

Motor Neuron Disease (Phase 2)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 3)

Nasopharyngeal Carcinoma (Phase 2)

Neoplasm Metastasis (Phase 3)

Neoplasms (Phase 2)

Neoplasms, Second Primary (Phase 2)

Nephritis, Hereditary (Phase 2)

Nephrosis (Phase 3)

Nephrosis, Lipoid (Phase 3)

Nephrotic Syndrome (Phase 3)

Neuralgia (Phase 3)

Ovarian Neoplasms (Phase 4)

Pancreatic Neoplasms (Phase 2)

Peripheral Nervous System Diseases (Phase 3)

Polycystic Kidney, Autosomal Dominant (Phase 3)

Polycystic Kidney Diseases (Phase 3)

Polycythemia (Phase 3)

Polycythemia Vera (Phase 3)

Pre-Eclampsia (Phase 3)

Proteinuria (Phase 3)

Renal Insufficiency (Phase 3)

Renal Insufficiency, Chronic (Phase 2)

Respiratory Distress Syndrome (Phase 4)

Respiratory Distress Syndrome, Newborn (Phase 4)

Respiratory Insufficiency (Phase 4)

Respiratory Sounds (Phase 4)

Respiratory Tract Infections (Phase 4)

Retinal Diseases (Phase 3)

Sarcoma (Phase 1)

Schizophrenia (Phase 4)

Sclerosis (Phase 2)

Shock (Phase 3)

Shock, Septic (Phase 3)

Squamous Cell Carcinoma of Head and Neck (Phase 3)

Syndrome (Phase 4)

Triple Negative Breast Neoplasms (Phase 2)

Uremia (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Vomiting (Phase 3)